A Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Allergic Conjunctivitis
Status:
Completed
Trial end date:
2020-02-28
Target enrollment:
Participant gender:
Summary
The objective of the study is to evaluate the efficacy and safety of OTX-DP as a
dexamethasone ophthalmic insert when placed in the canaliculus of the eyelid for the
treatment of the signs and symptoms of allergic conjunctivitis.